Engert A - Search Results

1

Successful treatment of disseminated human Hodgkin's disease in SCID mice with deglycosylated ricin A-chain immunotoxins.

Winkler U, Gottstein C, Schön G, Kapp U, Wolf J, Hansmann ML, Bohlen H, Thorpe P, Diehl V, Engert A. Winkler U, et al. Among authors: engert a. Blood. 1994 Jan 15;83(2):466-75. Blood. 1994. PMID: 8286745 Free article.

2

Experimental therapy in Hodgkin's disease.

Engert A, Pohl C, Diehl V. Engert A, et al. Ann Oncol. 1992 Sep;3 Suppl 4:97-100. doi: 10.1093/annonc/3.suppl_4.s97. Ann Oncol. 1992. PMID: 1333274

3

An overview of the Second International Symposium on Hodgkin's disease.

Diehl V, Engert A. Diehl V, et al. Among authors: engert a. Ann Oncol. 1992 Sep;3 Suppl 4:1-3. doi: 10.1093/annonc/3.suppl_4.s1. Ann Oncol. 1992. PMID: 1360252 No abstract available.

4

Preliminary report: growth of Hodgkin's lymphoma derived cells in immune compromised mice.

Kapp U, Wolf J, von Kalle C, Tawadros S, Röttgen A, Engert A, Fonatsch C, Stein H, Diehl V. Kapp U, et al. Among authors: engert a. Ann Oncol. 1992 Sep;3 Suppl 4:21-3. doi: 10.1093/annonc/3.suppl_4.s21. Ann Oncol. 1992. PMID: 1450076

5

Growth of Hodgkin cell lines in severely combined immunodeficient mice.

von Kalle C, Wolf J, Becker A, Sckaer A, Munck M, Engert A, Kapp U, Fonatsch C, Komitowski D, Feaux de Lacroix W, et al. von Kalle C, et al. Among authors: engert a. Int J Cancer. 1992 Dec 2;52(6):887-91. doi: 10.1002/ijc.2910520610. Int J Cancer. 1992. PMID: 1459730

6

[New perspectives in oncology: is selective destruction of tumor cells with immunotoxins in Hodgkin's disease an additional therapeutic alternative?].

Engert A, Gottstein C, Winkler U, Schön G, Amlot P, Thorpe P, Diehl V. Engert A, et al. Med Klin (Munich). 1992 Oct 15;87(10):503-9. Med Klin (Munich). 1992. PMID: 1461215 Review. German.

7

Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice.

Engert A, Martin G, Pfreundschuh M, Amlot P, Hsu SM, Diehl V, Thorpe P. Engert A, et al. Cancer Res. 1990 May 15;50(10):2929-35. Cancer Res. 1990. PMID: 1692251

8

Controversies in the management of non-Hodgkin lymphoma.

Engert A, Diehl V. Engert A, et al. Eur J Cancer. 1991;27(3):309-15. doi: 10.1016/0277-5379(91)90536-m. Eur J Cancer. 1991. PMID: 1827323 Review. No abstract available.

9

Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in mice.

Engert A, Martin G, Amlot P, Wijdenes J, Diehl V, Thorpe P. Engert A, et al. Int J Cancer. 1991 Sep 30;49(3):450-6. doi: 10.1002/ijc.2910490324. Int J Cancer. 1991. PMID: 1917143

10

Resistance of myeloid leukaemia cell lines to ricin A-chain immunotoxins.

Engert A, Brown A, Thorpe P. Engert A, et al. Leuk Res. 1991;15(11):1079-86. doi: 10.1016/0145-2126(91)90115-a. Leuk Res. 1991. PMID: 1961012

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

597 results

Search Page

Filters